Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1993-4-13
|
pubmed:abstractText |
In the colon-26 (C-26) tumor model, the cytokine IL-6 is an important factor involved in experimental cancer cachexia. Recent in vitro data indicated that IL-1 plays a role in the interaction between host macrophages and C-26 cells that express IL-1R, resulting in the amplification of tumor IL-6 production. To investigate the role of IL-1 on the development of C-26 cachexia in vivo, the effect of specific blockade of the action of IL-1 with reagents against IL-1R was evaluated. Both IL-1R antagonist (IL-1RA) and the mAb 35F5 directed against IL-1R type I, prevented binding of radioactive IL-1, and inhibited IL-1-induced IL-6 synthesis by the C-26 cell line. Whereas a systemic administration of these reagents did not reverse weight loss in C-26-bearing mice, intratumoral injections of IL-1RA significantly reduced cachexia. Furthermore, body composition analysis confirmed that this treatment improved lean tissue and fat, as well as hypoglycemia and serum IL-6 level. The fact that the treatment did not change the tumor burden suggests that it affected the host directly. These results support the hypothesis that, at the microenvironment of the C-26 tumor, IL-1 is involved in the cachexia endured by the host.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/IL1RN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Il1rn protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
150
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2341-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8450216-Animals,
pubmed-meshheading:8450216-Cachexia,
pubmed-meshheading:8450216-Colonic Neoplasms,
pubmed-meshheading:8450216-Humans,
pubmed-meshheading:8450216-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:8450216-Interleukin-1,
pubmed-meshheading:8450216-Male,
pubmed-meshheading:8450216-Mice,
pubmed-meshheading:8450216-Neoplasm Transplantation,
pubmed-meshheading:8450216-Neoplasms, Experimental,
pubmed-meshheading:8450216-Sialoglycoproteins
|
pubmed:year |
1993
|
pubmed:articleTitle |
Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor.
|
pubmed:affiliation |
Department of Immunology, Otsuka America Pharmaceutical Inc., Rockville, MD 20850.
|
pubmed:publicationType |
Journal Article
|